Welcome to HSCO
- HSCO Mini Symposia
April 7, 2010, with guest speaker Bruce Minsky, MD,
and July 21, ASH Update - RAC: CMS-Approved Audit Issues
Which Claims Will Be
Automatically Edited?
- From Medscape Oncology
Community Perspective on Multiple Myeloma: Management Strategies
Interview with Drs. Dragon and Skorupa (Log in required.)
- From Medscape Oncology
Expert and Community Perspectives from ASCO: Evidence-Based Treatment of Solid Tumors (GU, GI, and Lung Cancers)
- Write Congress Now
About 2010 Proposed Physician Fee Schedule - Support Bill to Remove Prompt Pay Discount from ASP
Write Congress Now! - HSCO Spring 2009 Newsline
Featuring: A Message from the HSCO President and Drugs in the News
HSCO 2009
Corporate Members:
GOLD:
AstraZeneca, LP
Bayer HealthCare Pharmaceuticals/Onyx
Celgene
Genentech, Inc.
Novartis Oncology
sanofi-aventis
SILVER:
Abraxis BioScience
Amgen Inc.
Cephalon
The Hawaii Society of Clinical Oncology (HSCO) represents the common interests of a majority of the oncologists treating cancer in Hawaii. HSCO is a chapter member of the Association of Community Cancer Centers and an affiliate of the American Society of Clinical Oncology.
Mission and Background
Vision Statement
The Hawaii Society of Clinical Oncology strives to be identified as the voice of Hawaii's oncologists to promote quality of oncology care through patient advocacy, continuing education, multidisciplinary engagement and participation in the public forum.
Mission Statement
The Hawaii Society of Clinical Oncology strives to represent all of its members in efforts to advance quality oncology care across Hawaii, provide a forum for all physicians interested in oncology to share their common concerns, and act as a vehicle for discussion of oncology practice, continuing education and access to quality oncology care issues.
Goals:
- Advance quality oncology care and access across Hawaii
- Provide a forum for all physicians interested in oncology to share their common concerns, and
- Act as a vehicle for discussion of oncology practice, continuing education and access to quality oncology care issues.
Objectives:
- Identify issues of concern to the membership
- Promote grassroots advocacy by developing relationships with other oncology interested groups
- Provide a forum for discussion on clinical trials legislation and outcomes research
- Monitor and respond to appropriate legislative and regulatory concerns of the membership
- Provide continuing education dinners for membership
- Provide value to the membership
- Enhanced communication with the membership.
